Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.8 |